![Nina Løvbakken](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Olav Steinnes | M | 67 |
Inven2 AS
![]() Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 Jahre |
Ole Kristian Skaar | M | - |
Inven2 AS
![]() Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 Jahre |
Ole Kristian Hjelstuen | M | - |
Inven2 AS
![]() Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 12 Jahre |
Magnus Gulbrandsen | M | - |
Inven2 AS
![]() Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Norwegen | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Nina Løvbakken
- Persönliches Netzwerk